EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Mannose-Functionalized Isoniazid-Loaded Nanostructured Lipid Carriers for Pulmonary Delivery: In Vitro Prospects and In Vivo Therapeutic Efficacy Assessment

Shaveta Ahalwat, Dinesh Chandra Bhatt, Surbhi Rohilla, Vikas Jogpal, Kirti Sharma, Tarun Virmani iD, Girish Kumar iD, Abdulsalam Alhalmi iD, Ali S Alqahtani iD, Omar M Noman iD, Marwan Almoiliqy

Pharmaceuticals · 04.08.2023 · 16 (8) · 1108

DOI: 10.3390/ph16081108 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceuticals, online erschienen am 04.08.2023. Verfasst von Shaveta Ahalwat und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Medical and Allied Sciences, G. D. Goenka University, Gurugram 122103, India. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: King Saud University, Riyadh, Saudi Arabia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Resistance to isoniazid (INH) is common and increases the possibility of acquiring multidrug-resistant tuberculosis. For this study, isoniazid-loaded nanostructured lipid carriers (INH-NLCs) were developed and effectively functionalized with mannose (Man) to enhance the residence time of the drug within the lungs via specific delivery and increase the therapeutic efficacy of the formulation. The mannose-functionalized isoniazid-loaded nanostructured lipid carrier (Man-INH-NLC) formulation was evaluated with respect to various formulation parameters, namely, encapsulation efficiency (EE), drug loading (DL), average particle size (PS), zeta potential (ZP), polydispersity index (PDI), in vitro drug release (DR), and release kinetics. The in vitro inhalation behavior of the developed formulation after nebulization was investigated using an Andersen cascade impactor via the estimation of the mass median aerosolized diameter (MMAD) and geometric aerodynamic diameter (GAD) and subsequently found to be suitable for effective lung delivery. An in vivo pharmacokinetic study was carried out in a guinea pig animal model, and it was demonstrated that Man-INH-NLC has a longer residence time in the lungs with improved pharmacokinetics when compared with unfunctionalized INH-NLC, indicating the enhanced therapeutic efficacy of the Man-INH-NLC formulation. Histopathological analysis led us to determine that the extent of tissue damage was more severe in the case of the pure drug solution of isoniazid compared to the Man-INH-NLC formulation after nebulization. Thus, the nebulization of Man-INH-NLC was found to be safe, forming a sound basis for enhancing the therapeutic efficacy of the drug for improved management in the treatment of pulmonary tuberculosis.

Schlagwörter

Stichwörter der Autor:innen

drug release profilehistopathological toxicityin vivo pharmacokineticsisoniazidmannosylationnanostructured lipid carriers

Autor:innen und Institutionen

  • School of Medical and Allied Sciences, G. D. Goenka University, Gurugram 122103, India.
  • Department of Pharmaceutical Sciences, Guru Jambheshwar University of Science and Technology, Hisar 125001, India.
  • School of Pharmaceutical Sciences, MVN University, Palwal 121105, India.
  • Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi 110062, India.
  • Department of Pharmacognosy, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia.
  • Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

ORCID-Profile: Tarun Virmani, Girish Kumar, Abdulsalam Alhalmi, Ali S Alqahtani, Omar M Noman

Förderung

  • King Saud University, Riyadh, Saudi Arabia

Zitieren

APA

Ahalwat, S., Bhatt, D. C., Rohilla, S., Jogpal, V., Sharma, K., Virmani, T., Kumar, G., Alhalmi, A., Alqahtani, A. S., Noman, O. M., & Almoiliqy, M. (2023). Mannose-Functionalized Isoniazid-Loaded Nanostructured Lipid Carriers for Pulmonary Delivery: In Vitro Prospects and In Vivo Therapeutic Efficacy Assessment. Pharmaceuticals, 16(8), 1108. https://doi.org/10.3390/ph16081108

Vancouver

Ahalwat S, Bhatt DC, Rohilla S, Jogpal V, Sharma K, Virmani T, et al. Mannose-Functionalized Isoniazid-Loaded Nanostructured Lipid Carriers for Pulmonary Delivery: In Vitro Prospects and In Vivo Therapeutic Efficacy Assessment. Pharmaceuticals. 2023;16(8):1108. doi:10.3390/ph16081108

BibTeX
@article{Ahalwat2023,
  author = {Ahalwat, Shaveta and Bhatt, Dinesh Chandra and Rohilla, Surbhi and Jogpal, Vikas and Sharma, Kirti and Virmani, Tarun and Kumar, Girish and Alhalmi, Abdulsalam and Alqahtani, Ali S and Noman, Omar M and Almoiliqy, Marwan},
  title = {Mannose-Functionalized Isoniazid-Loaded Nanostructured Lipid Carriers for Pulmonary Delivery: In Vitro Prospects and In Vivo Therapeutic Efficacy Assessment},
  journal = {Pharmaceuticals},
  year = {2023},
  volume = {16},
  number = {8},
  pages = {1108},
  doi = {10.3390/ph16081108}
}
Kostenlos starten →